Norditropin 30iu (10mg)

$250

9 products sold in last 1 hour
Selling fast! Over 2 people have in their cart
30 people are viewing this right now
  • Check Mark Estimated Delivery : Up to 4 business days
  • Check Mark Free Shipping & Returns : On all orders over $200
  • Visa Card
  • MasterCard
  • American Express
  • Discover Card
  • PayPal
  • Apple Pay
Guaranteed Safe And Secure Checkout

Norditropin 30iu (10mg)

Norditropin 30iu (10mg) is a prescription somatropin product from Novo Nordisk. It contains recombinant human growth hormone and is supplied as a clear, colorless solution for subcutaneous injection. The 10 mg/1.5 mL strength is equivalent to approximately 30 IU because 1 mg of somatropin corresponds to 3 IU.

Product Details

Active ingredient: Somatropin (recombinant human growth hormone)
Strength: 10 mg/1.5 mL
Equivalent amount: Approximately 30 IU per 1.5 mL
Dosage form: Solution for subcutaneous injection
Presentation: Cartridge or compatible pen presentation, depending on the market and supplied pack
Manufacturer: Novo Nordisk
Appearance: Clear and colourless solution

Norditropin is intended for patients who require medically prescribed growth hormone therapy. Somatropin has the same amino-acid sequence as naturally occurring human growth hormone and is produced using recombinant DNA technology. It acts on growth and metabolism and is used when a healthcare professional has confirmed an appropriate medical indication.

What Norditropin Is Used For

Depending on the country and approved product label, Norditropin 30iu (10mg) may be prescribed for children with growth failure caused by growth hormone deficiency, Turner syndrome, chronic renal disease-related growth problems, or children born small for gestational age who have not achieved expected catch-up growth.

It may also be prescribed as growth hormone replacement therapy for adults with confirmed growth hormone deficiency.

Norditropin should not be used simply for bodybuilding, athletic performance, cosmetic purposes, or general anti-ageing. Treatment requires medical assessment because the appropriate dose depends on factors such as diagnosis, body weight or body surface area, age, treatment response, and laboratory monitoring.

Administration Information

Norditropin is administered by subcutaneous injection. The exact dose and injection schedule must be determined by the prescribing healthcare professional. Injection sites should be rotated regularly to help reduce the risk of local tissue changes.

Patients should use the injection device and needle system intended for the exact Norditropin presentation supplied to them. The manufacturer’s instructions should be read carefully before the first injection.

Do not use the solution if it appears cloudy, discoloured, frozen, damaged, or different from its normal clear and colourless appearance. Needles should not be shared, and a new needle should be used for each injection where required by the device instructions.

Storage and Handling

Unopened Norditropin should normally be stored in a refrigerator at 2°C to 8°C and protected from light. It must not be frozen or kept directly next to a refrigerator cooling element.

Storage requirements after first use can depend on the exact Norditropin device and regional product information. Current Norditropin FlexPro information allows storage after first use for up to four weeks at 2°C to 8°C or, alternatively, up to three weeks below 25°C.

Always follow the storage instructions printed on the carton and patient information leaflet supplied with the specific product.

Important Safety Information

Somatropin is not suitable for every patient. It may be contraindicated in certain situations, including active malignancy and some acute critical illnesses. Additional medical monitoring may be necessary for patients with diabetes, thyroid disorders, intracranial hypertension, previous cancer treatment, or other conditions that may affect growth hormone therapy.

Possible adverse effects can include injection-site reactions, headache, fluid retention, joint or muscle discomfort, changes in glucose control, and other treatment-related effects. New, persistent, or severe symptoms should be reviewed by a healthcare professional rather than managed by changing the dose without medical advice.

Pack Verification

Before use, check the product name, strength, batch number, expiry date, packaging condition, and manufacturer information. Norditropin presentations may vary between countries, so packaging, device type, and country-specific details should be confirmed directly from the supplied carton.

“SimpleXx” refers to a Norditropin cartridge presentation and should not be listed as the manufacturer name.

Norditropin 30iu (10mg) is a prescription medicine and should be supplied and used only according to applicable local regulations and the instructions of a qualified healthcare professional.